Key result
The PERFORM-CV score demonstrated good discrimination for in-hospital mortality (AUC 0.852; 95% CI 0.806-0.897; p<0.001), comparable to the Lee/RCRI and higher than the AUB-HAS2 index.
Why the study?
Traditional perioperative cardiovascular risk models rely primarily on clinical history and may not fully capture functional status, leaving risk assessment challenging in non-cardiac surgery.
Does the PERFORM-CV score accurately predict in-hospital mortality in non-cardiac surgical patients with cardiovascular comorbidity compared to established risk indices?
Cohort (n=503)
Yes
Does the PERFORM-CV score accurately predict in-hospital mortality in non-cardiac surgical patients with cardiovascular comorbidity compared to established risk indices?
The novel PERFORM-CV score, which integrates clinical, laboratory, and echocardiographic data, provides good discrimination for in-hospital mortality in non-cardiac surgery patients, performing comparably to the established Lee/RCRI.
Answers are grounded in this paper and cite their sources.
May improve risk stratification in CV patients undergoing non-cardiac surgery; extends established indices but requires prospective validation.
Background: Perioperative cardiovascular risk assessment remains challenging in non-cardiac surgery, particularly in older patients and those with multiple comorbidities. Traditional models rely largely on clinical history and may not fully reflect current cardiovascular functional status. This study aimed to derive and assess the apparent performance of a new composite score, PERFORM-CV, integrating clinical, laboratory, and echocardiographic data. Methods: We conducted a prospective two-center cohort study including 503 non-cardiac surgical patients with cardiovascular comorbidity. The Revised Cardiac Risk Index (Lee/RCRI) and the AUB-HAS2 index were calculated according to their original published definitions as raw point totals ranging from 0 to 6; without additional normalization. The PERFORM-CV score was derived from univariable and multivariable analyses, with continuous predictors dichotomized using ROC-derived thresholds. Results: Emergency admission, chronic heart failure, and elevated serum creatinine remained independently associated with in-hospital mortality. Lower left ventricular ejection fraction, lower mitral annular plane systolic excursion (MAPSE), lower hemoglobin, and atrial fibrillation also contributed to the final composite score. ROC analysis showed good discrimination for PERFORM-CV (AUC 0.852; 95% CI 0.806–0.897; p < 0.001), comparable to Lee/RCRI (AUC 0.860; 95% CI 0.818–0.901; p < 0.001) and higher than AUB-HAS2 (AUC 0.779; 95% CI 0.731–0.826; p < 0.001). Conclusions: PERFORM-CV showed good apparent discrimination in the derivation cohort and may complement established bedside risk tools by incorporating echocardiographic and laboratory data. The ROC-derived thresholds should be interpreted as data-driven derivation cut-offs; resampling-based internal validation and external validation are required before broader clinical use.
No takes yet. Share an insight, caveat, or question.
Boghean et al. (2026) conducted a cohort in Non-cardiac surgical patients with cardiovascular comorbidity (n=503). PERFORM-CV score vs. Lee/RCRI and AUB-HAS2 indices was evaluated on In-hospital mortality (AUC 0.852, 95% CI 0.806-0.897, p=<0.001). The PERFORM-CV score demonstrated good discrimination for in-hospital mortality (AUC 0.852; 95% CI 0.806-0.897; p<0.001), comparable to the Lee/RCRI and higher than the AUB-HAS2 index.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: